| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |